Physiologically based kinetic model of effector cell biodistribution in mammals: Implications for adoptive immunotherapy

Cancer Research

Volumn 56, Issue 16, 1996, Pages 3771-3781

  Zhu, Hui ^a,b   Melder, Robert J ^a   Baxter, Laurence T ^a   Jain, Rakesh K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ARTICLE; BLOOD FLOW VELOCITY; CANCER IMMUNOTHERAPY; CELL KINETICS; CELLULAR DISTRIBUTION; EFFECTOR CELL; HUMAN; HUMAN CELL; LYMPH FLOW; LYMPHOCYTE MIGRATION; MATHEMATICAL MODEL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR VOLUME;

ANIMALS; CELL MOVEMENT; HUMANS; IMMUNOTHERAPY, ADOPTIVE; KINETICS; MICE; MODELS, BIOLOGICAL; RATS; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTES;

EID: 0029783873     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Rosenberg, S. A. The immunotherapy and gene therapy of cancer. J Clin. Oncol., 10: 180-199, 1992.
2. Jain, R. K. 1995 Whitaker Lecture: Delivery of molecules, particles, and cells to solid tumors Ann. Biomed. Eng., 24: 457-473, 1995
3. Jain, R K. Delivery of molecular medicine to solid tumors. Science (Washington DC), 271: 1079-1080, 1996.
4. Topalian, S. L., and Rosenberg, S. A. Adoptive cellular therapy: basic principles. In. V DeVita, Jr , S. Hellman, and S. Rosenberg (eds.), Biologic Therapy of Cancer, pp. 178-196. Philadelphia: J. B. Lippincott Company, 1991
5. Basse, P., and Goldfarb, R. H. Localization of immune effector cells to tumor metastases. In: R. Goldfarb and T. Whiteside (eds), Tumor Immunology and Cancer Therapy, pp. 149-158. New York: Marcel Dekker, Inc., 1994.
6. Whiteside, T. L., and Goldfarb, R. H. Antitumor effector cells: extravasation and control of metastasis. In: R. Goldfarb and T. Whiteside (eds.), Tumor Immunology and Cancer Therapy, pp. 159-173. New York: Marcel Dekker, Inc., 1994.
7. De Boer, R. J., Hogeweg, P., Dullen, H. F , De Weger, R. A., and Den Otter, W. Macrophage T lymphocyte interaction in the anti-tumor immune response: a mathematical model. J. Immunol., 134: 2748-2758, 1985.
8. De Boer, R. J., and Hogeweg, P. Interaction between macrophages and T lymphocytes: tumor sneaking through intrinsic to helper T cell dynamics. J. Theoret. Biol., 120: 331-351, 1986
9. Greenberg, P. D Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells. Adv. Immunol., 49: 281-355, 1991
10. Kuznetsov, V. A , Makalkin, I. A., Taylor, M. A., and Perelson, A. S. Nonlinear dynamics of immunogenic tumors parameter estimation and global bifurcation analysis. Bull. Math. Biol., 50: 295-321, 1994.
11. Ohkubo, C., Bigos, D., and Jain, R K. IL-2 induced leukocyte adhesion to the normal and tumor microvascular endothelium in vivo and its inhibition by dextran sulfate: implications for vascular leak syndrome. Cancer Res., 51: 1561-1563, 1991.
12. Edwards, M. J., Miller, F. N., Sims, D. E , Abney, D. L , Schuschke, D. A., and Corey, T. S. Interleukin 2 acutely induces platelet and neutrophil-endothelial adherence and macromolecular leakage. Cancer Res., 52: 3425-3431, 1992.
13. Fisher, B., Packard, B S., Read, E. J., Carrasquillo, J A., Carter, C S., Topalian, S. L., Yang, J , Yolles, P., Larson, S., and Rosenberg, S. A Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma. J. Clin. Oncol., 7: 250-261, 1989
14. Maghazachi, A. A., Herberman, R. B , Vujanovic, N. L , and Hiserodt, J. C. In vivo distribution and tissue location of highly purified rat lymphokine activated killer (LAK) cells. Cell. Immunol , 115: 179-194, 1988.
15. Sasaki, A., Melder, R. J., Whiteside, T. L., Herberman, R. B., and Jain, R. K. Preferential localization of human adherent lymphokine-activated killer (A-LAK) cells in tumor microcirculation J. Natl. Cancer Inst., 83: 433-437, 1991.
16. Basse, P., Herberman, R. B , Nannmark, U., Johansson, B. R., Hokland, M., Wasserman, K , and Goldfarb, R. H. Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases J Exp. Med., 174: 479-488, 1991.
17. Basse, P., Nannmark, U., Johansson, B. R., Herberman, R. B., and Goldfarb, R. H. Establishment of cell-to-cell contact by adoptively transferred adherent lymphokine-activated killer cells with metastatic murine melanoma cells J. Natl. Cancer Inst., 83: 944-950, 1991.
18. Basse, P , Herberman, R. B., Hokland, M., and Goldfarb, R. H. Tissue distribution of adoptively transferred adherent lymphokine-activated killer cells assessed by different labels Cancer Immunol. Immunother., 34: 221-227, 1992.
19. Melder, R. J , Brownell, A. L., Shoup, T. M., Brownell, G. L , and Jain, R. K. Imaging of activated natural killer cells in mice by positron emission tomography: preferential uptake in tumors. Cancer Res., 53: 5867-5871, 1993.
20. Melder, R. J., Elmaleh, D , Brownell, A. L., Brownell, G. L , and Jain, R. K. A method for labeling cells for positron emission tomography (PET) studies. J Immunol Methods, 175: 79-87, 1994.
21. Melder, R. J., Salehi, H. A., and Jain, R. K. Localization of activated natural killer cells in MCaIV mammary carcinoma grown in cranial windows in C3H mice Microvasc. Res, 50: 35-44, 1995.
22. Wallace, P. K., Palmer, L. D., Perry-Lalley, D., Bolton, E. S., Alexander, R. B , Horan, P. K., Yang, J. C., and Muirhead, K. A. Mechanisms of adoptive immunotherapy: improved methods for in vivo tracking of tumor-infiltrating lymphocytes and lymphokine-activated killer cells Cancer Res , 53: 2358-2367, 1993.
23. Bischoff, K. B., Dedrick, R. L , Zaharko, D S , and Longstreth, J. A. Methotrexate pharmacokinetics. J. Pharmaceut. Sci., 60: 1128-1133, 1971
24. Gerlowski, L. E., and Jain, R. K. Physiologically based pharmacokinetic modeling: principles and applications. J. Pharmaceut. Sci., 72: 1103-1123, 1983.
25. Baxter, L T., Zhu, H., Butler, W. F., and Jain, R. K. Physiologically based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice. Cancer Res., 54: 1517-1528, 1994.
26. Baxter, L T., Zhu, H., Mackensen, D. G., Butler, W. F., and Jain, R. K. Biodistribution of monoclonal antibodies: scale-up from mouse to man using a physiologically based pharmacokinetic model Cancer Res., 55: 4611-4622, 1995.
27. Zhu, H , Baxter, L T., and Jain, R. K. Potential and limitations of radioimmunodetection and radioimmunotherapy using monoclonal antibodies: evaluation with a physiologically based pharmacokinetic model J. Nucl. Med , in press, 1996.
28. Herberman, R. B., Reynolds, C. W., and Ortaldo, J. R Mechanism of cytotoxicity by natural killer (NK) cells. Annu. Rev. Immunol., 4: 651-680, 1986.
29. Melder, R. J , Whiteside, T. L , Vujanovic, N. L , Hiserodt, J. C., and Herberman, R B. A new approach of generating antitumor effectors for adoptive immunotherapy using adherent lymphokine activated killer cells Cancer Res , 48: 3461-3459, 1988.
30. Reynolds, C. W., Denn, A. C., III, Barlozzan, T., Wiltrout, R. H., Reichardt, D. A., and Herberman, R B Natural killer activity in the rat. IV. Distribution of large granular lymphocytes (LGL) following intravenous and intraperitoneal transfer. Cell. Immunol., 86: 371-380, 1984
31. Abbas, A. K., Lichtman, A. H , and Pober, J. S Cellular and Molecular Immunology. Philadelphia: W. B. Saunders Company, 1994.
32. Springer, T. A. Traffic signals for lymphocyte recirculation and leukocyte emigration the multistep paradigm. Cell, 76: 301-314, 1994.
33. Rolstad, B., Herberman, R. B., and Reynolds, C. W. Natural killer activity in the rat. V. The circulation pattern and tissue localization of peripheral blood large granular lymphocytes (LGL). J. Immunol., 136: 2800-2808, 1986.
34. Ottaway, C. A. The efficiency of entry of lymphoid cells into lymphoid and nonlymphoid tissues. Adv. Exp. Med. Biol., 149: 219-224, 1982.
35. Alon, R., Hammer, D. A , and Springer, T. A. Lifetime of the P-selectin-carbohydrate bond and its response to tensile force in hydrodynamic flow. Nature (Lond), 374: 539-542, 1995.
36. Jain, R K Determinants of tumor blood flow: a review. Cancer Res., 48: 2641-2658, 1988.
37. Bjerknes, M , Cheng, H., and Ottaway, C. A. Dynamics of lymphocyte-endothelial interactions in vivo. Science (Washington DC), 231: 402-405, 1986.
38. Greenwood, J., and Calder, V L. Lymphocyte migration through cultured endothelial cell monolayers derived from blood-retina barrier Immunology, 80: 401-406, 1993.
39. Butcher, E. C., and Ford, W. L. Following cellular traffic: methods of labeling lymphocytes and other cells to trace their migration in vivo. In: D. M. Weir (ed), Handbook of Experimental Immunology, pp. 57:1-57.23, 1984.
40. Dedrick, R. L. Animal scale-up. J Pharmacokinet. Biopharmaceut , 1: 435-461, 1973.
41. Wilkinson, P C. Locomotion and chemotaxis of leukocytes In: D. M. Weir (ed.), Handbook of Experimental Immunology. Oxford: Blackwell Scientific Publications, pp 51.1-51.16, 1984
42. Melder, R. J., Walker, E. R., Herberman, R B., and Whiteside, T. L. Surface characteristics, morphology, and ultrastructure of human adherent lymphokine-activated killer cells J. Leuk. Biol., 48 163-173, 1990.
43. Matsumura, T., Sussman, J. J., Krinock, R A., Chang, A. E., and Shu, S. Characteristics and in vivo homing of long-term T-cell lines and clones derived from tumor-draining lymph nodes. Cancer Res , 54: 2744-2750, 1994.
44. Jain, R K., Koenig, G. C., Dellian, M., Fukumura, D., Munn, L. L , and Melder, R J. Leukocyte-endothelial adhesion and angiogenesis in tumors. Cancer Metastasis Rev., in press, 1996.
45. Mizoguchi, H., O'Shea, J. J , Longo, D. L., Loeffler, C. M., McVicar, D W., and Ochoa, A. C. Alterations in signal transduction molecules in T lymphocytes from tumor bearing mice. Science (Washington DC), 258: 1795-1798, 1992.
46. Sasaki, A., Jain, R. K., Maghazachi, A. A., Goldfarb, R. H , and Herberman, R. B. Low deformability of lymphokine-activated killer cells as a possible determinant of in vivo distribution. Cancer Res., 49 3742-3746, 1989.
47. Worthen, G. S., Schwab, B., III, Elson, E L., and Downey, G P. Mechanics of stimulated neutrophils: cell stiffening induces retention in capillaries. Science (Washington DC), 245: 183-186, 1989.
48. Melder, R J , and Jain, R K. Kinetics of interleukin-2 induced changes in rigidity of human natural killer cells. Cell Biophys., 20: 161-176, 1992
49. Melder, R. J., and Jain, R. K. Reduction of rigidity in human activated natural killer cells by thioglycollate treatment J. Immunol. Methods, 175: 69-77, 1994.
50. Fogler, W. E., McCormick, K. L., Volker, K., Ortaldo, J. R., and Wiltrout, R. H. NK cell infiltration into lung is primarily regulated by VCAM-1. In: Experimental Biology 95, A219 Atlanta: FASEB, 1995.
51. Nannmark, U., Johansson, B. R., Bryant, J. L , Unger, M L., Hokland, M. E., Goldfarb, R. H., and Basse, P H. Microvessel origin and distribution in pulmonary metastases of B16 melanoma: implication for adoptive immunotherapy Cancer Res , 55 4627-4632, 1995.
52. Hindmarsh, A. C. LSODE and LSODI: two new initial value ordinary differential equation solvers. ACM Signum Newsletter, 15: 10-11, 1980.